Identifying LRRC16B as an oncofetal gene with transforming enhancing capability using a combined bioinformatics and experimental approach

Oncogene. 2011 Feb 10;30(6):654-67. doi: 10.1038/onc.2010.451. Epub 2010 Nov 22.

Abstract

Oncofetal genes are expressed in embryos or fetuses, are downregulated or undetectable in adult tissues, and then re-expressed in tumors. Known oncofetal genes, such as AFP, GCB, FGF18, IMP-1 and SOX1, often have important clinical applications or pivotal biological functions. To find new oncofetal-like genes, we used the public information of expressed sequence tags to systematically analyze gene expression patterns and identified a novel oncofetal-like gene, LRRC16B. It increased the proliferation, anchorage-independent growth and tumorigenesis of transformed cells in xenografts, possibly through its effects on cyclin B1 protein levels. These findings exemplify the feasibility of using bioinformatics to find new oncofetal-like genes and suggest that more genes with important functional roles will be uncovered in the candidate gene list.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Neoplasm / genetics*
  • Carrier Proteins
  • Cell Line
  • Cell Proliferation
  • Cell Transformation, Neoplastic / genetics*
  • Computational Biology / methods
  • Cricetinae
  • Cyclin B1 / metabolism
  • Databases, Genetic
  • Expressed Sequence Tags
  • Female
  • Humans
  • Mice
  • Mice, Inbred NOD
  • Microfilament Proteins
  • Xenograft Model Antitumor Assays

Substances

  • Antigens, Neoplasm
  • CARMIL1 protein, human
  • Carrier Proteins
  • Cyclin B1
  • Microfilament Proteins
  • oncofetal antigens